Cargando…

Cautions on the laboratory indicators of COVID‐19 patients on and during admission

BACKGROUND: Different disease severities of COVID‐19 patients could be reflected on clinical laboratory findings. METHODS: In this single‐centered retrospective study, demographic, clinical, and laboratory indicators on and during admission were compared among 74 participants with mild, moderate, cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Haiting, Shang, Xueling, Chen, Sai, Li, Tie, Zhang, Junhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128304/
https://www.ncbi.nlm.nih.gov/pubmed/33951237
http://dx.doi.org/10.1002/jcla.23767
_version_ 1783694096134569984
author Liu, Haiting
Shang, Xueling
Chen, Sai
Li, Tie
Zhang, Junhua
author_facet Liu, Haiting
Shang, Xueling
Chen, Sai
Li, Tie
Zhang, Junhua
author_sort Liu, Haiting
collection PubMed
description BACKGROUND: Different disease severities of COVID‐19 patients could be reflected on clinical laboratory findings. METHODS: In this single‐centered retrospective study, demographic, clinical, and laboratory indicators on and during admission were compared among 74 participants with mild, moderate, critical severe, or severe classification. Risk factors associated with disease severity were analyzed by multivariate analyses. The AUC and 95% CI of the ROC curve were calculated. RESULTS: The most common manifestations of these patients were fever and cough. Critical severe or severe group owned the longest length of stay (23 (19,31), p < 0.001). After multivariate logistic regression, independent influence factors on admission for severity of disease were CK‐MB (OR 0.674; 95% CI 0.489–0.928; p = 0.016), LDH (OR 1.111 or 1.107; 95% CI 1.026–1.204 or 1.022–1.199; p = 0.009 or 0.013), normal T‐BIL (OR 4.58 × 10(−8); 95% CI 3.05 × 10(−9)–6.88 × 10(−7); p < 0.001), LYM% (OR 0.008; 95% CI 0–0.602; p = 0.029), and normal ESR (OR 0.016; 95% CI 0–0.498; p = 0.019). Factors during hospitalization were normal T‐BIL (OR 8.56 × 10(−9); 95% CI 8.30 × 10(−10)–8.83 × 10(−8); p < 0.001), LYM (OR 0.068; 95% CI 0.005–0.934; p = 0.044), albumin (OR 0.565; 95% CI 0.327–0.977; p = 0.041), and normal NEU% (OR 0.013; 95% CI 0.000–0.967; p = 0.048). Combined indicators of AUC were 0.860 (LYM, LDH, and normal ESR on admission, p < 0.001) and 0.750 (CK‐MB, LDH, and normal T‐BIL during hospitalization, p = 0.020) when predicting for severe or critical severe patients. CONCLUSION: To pay close attention to the progression of COVID‐19 and take measures promptly, we should be cautious of the laboratory indicators when patients on admission especially CK‐MB, LDH, LYM%, T‐BIL as well as ESR; and T‐BIL, LYM, albumin, NEU% with the process of disease.
format Online
Article
Text
id pubmed-8128304
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81283042021-05-21 Cautions on the laboratory indicators of COVID‐19 patients on and during admission Liu, Haiting Shang, Xueling Chen, Sai Li, Tie Zhang, Junhua J Clin Lab Anal Research Articles BACKGROUND: Different disease severities of COVID‐19 patients could be reflected on clinical laboratory findings. METHODS: In this single‐centered retrospective study, demographic, clinical, and laboratory indicators on and during admission were compared among 74 participants with mild, moderate, critical severe, or severe classification. Risk factors associated with disease severity were analyzed by multivariate analyses. The AUC and 95% CI of the ROC curve were calculated. RESULTS: The most common manifestations of these patients were fever and cough. Critical severe or severe group owned the longest length of stay (23 (19,31), p < 0.001). After multivariate logistic regression, independent influence factors on admission for severity of disease were CK‐MB (OR 0.674; 95% CI 0.489–0.928; p = 0.016), LDH (OR 1.111 or 1.107; 95% CI 1.026–1.204 or 1.022–1.199; p = 0.009 or 0.013), normal T‐BIL (OR 4.58 × 10(−8); 95% CI 3.05 × 10(−9)–6.88 × 10(−7); p < 0.001), LYM% (OR 0.008; 95% CI 0–0.602; p = 0.029), and normal ESR (OR 0.016; 95% CI 0–0.498; p = 0.019). Factors during hospitalization were normal T‐BIL (OR 8.56 × 10(−9); 95% CI 8.30 × 10(−10)–8.83 × 10(−8); p < 0.001), LYM (OR 0.068; 95% CI 0.005–0.934; p = 0.044), albumin (OR 0.565; 95% CI 0.327–0.977; p = 0.041), and normal NEU% (OR 0.013; 95% CI 0.000–0.967; p = 0.048). Combined indicators of AUC were 0.860 (LYM, LDH, and normal ESR on admission, p < 0.001) and 0.750 (CK‐MB, LDH, and normal T‐BIL during hospitalization, p = 0.020) when predicting for severe or critical severe patients. CONCLUSION: To pay close attention to the progression of COVID‐19 and take measures promptly, we should be cautious of the laboratory indicators when patients on admission especially CK‐MB, LDH, LYM%, T‐BIL as well as ESR; and T‐BIL, LYM, albumin, NEU% with the process of disease. John Wiley and Sons Inc. 2021-05-05 /pmc/articles/PMC8128304/ /pubmed/33951237 http://dx.doi.org/10.1002/jcla.23767 Text en © 2021 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC
spellingShingle Research Articles
Liu, Haiting
Shang, Xueling
Chen, Sai
Li, Tie
Zhang, Junhua
Cautions on the laboratory indicators of COVID‐19 patients on and during admission
title Cautions on the laboratory indicators of COVID‐19 patients on and during admission
title_full Cautions on the laboratory indicators of COVID‐19 patients on and during admission
title_fullStr Cautions on the laboratory indicators of COVID‐19 patients on and during admission
title_full_unstemmed Cautions on the laboratory indicators of COVID‐19 patients on and during admission
title_short Cautions on the laboratory indicators of COVID‐19 patients on and during admission
title_sort cautions on the laboratory indicators of covid‐19 patients on and during admission
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128304/
https://www.ncbi.nlm.nih.gov/pubmed/33951237
http://dx.doi.org/10.1002/jcla.23767
work_keys_str_mv AT liuhaiting cautionsonthelaboratoryindicatorsofcovid19patientsonandduringadmission
AT shangxueling cautionsonthelaboratoryindicatorsofcovid19patientsonandduringadmission
AT chensai cautionsonthelaboratoryindicatorsofcovid19patientsonandduringadmission
AT litie cautionsonthelaboratoryindicatorsofcovid19patientsonandduringadmission
AT zhangjunhua cautionsonthelaboratoryindicatorsofcovid19patientsonandduringadmission